AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 288: G685-G695, 2005. First published November 18, 2004; doi:10.1152/ajpgi.00207.2004
0193-1857/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/G685    most recent
00207.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jahan, A.
Right arrow Articles by Chiang, J. Y. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jahan, A.
Right arrow Articles by Chiang, J. Y. L.

LIVER AND BILIARY TRACT

Cytokine regulation of human sterol 12{alpha}-hydroxylase (CYP8B1) gene

Asmeen Jahan and John Y. L. Chiang

Department of Biochemistry and Molecular Pathology, Northeastern Ohio Universities College of Medicine, Rootstown, Ohio

Submitted 6 May 2004 ; accepted in final form 15 November 2004

Sterol 12{alpha}-hydroxylase (CYP8B1) catalyzes cholic acid synthesis in the liver and is feedback inhibited by bile acids. In addition to activating farnesoid X receptor (nuclear receptor subfamily 1H4), bile acids also induce inflammatory cytokines in hepatocytes. The objective of this study was to investigate the mechanism by which inflammatory cytokines inhibit human CYP8B1 gene transcription. Real-time PCR assays revealed that both chenodeoxycholic acid (CDCA) and interleukin-1{beta} (IL-1{beta}) markedly reduced CYP8B1, cholesterol 7{alpha}-hydroxylase CYP7A1 and hepatic nuclear factor 4{alpha} (HNF4{alpha}) mRNA expression levels in human primary hepatocytes. However, CDCA induced, but IL-1{beta} reduced, small heterodimer partner (SHP) mRNA expression. IL-1{beta} inhibited human CYP8B1 reporter activity only in liver cells, and a c-Jun NH2-terminal kinase (JNK)-specific inhibitor-blocked IL-1{beta} inhibition. Activated JNK1 or c-Jun inhibited, whereas their dominant negative forms blocked, IL-1{beta} inhibition of CYP8B1 transcription. Mutagenesis analyses mapped an IL-1{beta} response element to a previously identified bile acid response element, which contains an HNF4{alpha} binding site. A dominant negative HNF4{alpha} inhibited CYP8B1 gene transcription and ectopically expressed HNF4{alpha} blocked IL-1{beta} inhibition. Furthermore, IL-1{beta} inhibited HNF4{alpha} gene transcription, protein expression, and binding to the CYP8B1 gene. JNK1 phosphorylated HNF4{alpha} and a JNK-specific inhibitor blocked the IL-1{beta} inhibition of HNF4{alpha} expression. These results suggest that IL-1{beta} inhibits CYP8B1 gene transcription via a mitogen-activated protein kinase/JNK pathway that inhibits HNF4{alpha} gene expression and its DNA-binding ability. This mechanism may play an important role in the adaptive response to inflammatory cytokines and in the protection of the liver during cholestasis.

bile acid synthesis; nuclear receptor; interleukin-1{beta}; hepatic nuclear factor 4{alpha}; cholestasis



Address for reprint requests and other correspondence: J. Y. L. Chiang, Dept. of Biochemistry and Molecular Pathology, Northeastern Ohio Universities College of Medicine, 4209 State Route 44, P. O Box 95, Rootstown, OH 44272 (E-mail: jchiang{at}neoucom.edu)




This article has been cited by other articles:


Home page
J. Nutr.Home page
Y. Li, O. Mezei, and N. F. Shay
Human and Murine Hepatic Sterol-12-{alpha}-Hydroxylase and Other Xenobiotic Metabolism mRNA Are Upregulated by Soy Isoflavones
J. Nutr., July 1, 2007; 137(7): 1705 - 1712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.